Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Foley

Showing results (861-870 of 911) with videos related to

Pageof 92
Sort By:
Circulation|October 27, 2024
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery DiseaseMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Science (New York, N.Y.)|May 11, 2023
Constraints on the Hubble constant from supernova Refsdal's reappearancePatrick L Kelly, Steven Rodney, Tommaso Treu, et al.
Nature|May 21, 2010
A faint type of supernova from a white dwarf with a helium-rich companionH B Perets, A Gal-Yam, P A Mazzali, et al.
Journal of the American College of Cardiology|May 16, 2024
N-of-1 Trial of Angina Verification Before Percutaneous Coronary InterventionChristopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Circulation|May 8, 2026
Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled StudyFiyyaz Ahmed-Jushuf, Michael J Foley, Shayna Chotai, et al.
Circulation|October 27, 2025
The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled StudyChristopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Science (New York, N.Y.)|March 7, 2015
Astrophysics. Multiple images of a highly magnified supernova formed by an early-type cluster galaxy lensPatrick L Kelly, Steven A Rodney, Tommaso Treu, et al.
Nature|September 28, 1999
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14R S Ames, H M Sarau, J K Chambers, et al.
Journal of the American College of Cardiology|May 17, 2024
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery DiseaseFlorentina A Simader, Christopher A Rajkumar, Michael J Foley, et al.
Lancet (London, England)|April 11, 2024
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 92

Showing results (861-870 of 911) with videos related to

Sort By:
Pageof 92
Circulation|October 27, 2024
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery DiseaseMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Science (New York, N.Y.)|May 11, 2023
Constraints on the Hubble constant from supernova Refsdal's reappearancePatrick L Kelly, Steven Rodney, Tommaso Treu, et al.
Nature|May 21, 2010
A faint type of supernova from a white dwarf with a helium-rich companionH B Perets, A Gal-Yam, P A Mazzali, et al.
Journal of the American College of Cardiology|May 16, 2024
N-of-1 Trial of Angina Verification Before Percutaneous Coronary InterventionChristopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Circulation|May 8, 2026
Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled StudyFiyyaz Ahmed-Jushuf, Michael J Foley, Shayna Chotai, et al.
Circulation|October 27, 2025
The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled StudyChristopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Science (New York, N.Y.)|March 7, 2015
Astrophysics. Multiple images of a highly magnified supernova formed by an early-type cluster galaxy lensPatrick L Kelly, Steven A Rodney, Tommaso Treu, et al.
Nature|September 28, 1999
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14R S Ames, H M Sarau, J K Chambers, et al.
Journal of the American College of Cardiology|May 17, 2024
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery DiseaseFlorentina A Simader, Christopher A Rajkumar, Michael J Foley, et al.
Lancet (London, England)|April 11, 2024
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Pageof 92